U.S. markets open in 9 hours 5 minutes

CLASS ACTION UPDATE for WORX, SRNE and CCL: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

NEW YORK, NY / ACCESSWIRE / June 3, 2020 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court. Further details about the cases can be found at the links provided. There is no cost or obligation to you.

WORX Shareholders Click Here: https://www.zlk.com/pslra-1/scworx-corp-loss-submission-form?prid=7125&wire=1
SRNE Shareholders Click Here: https://www.zlk.com/pslra-1/sorrento-therapeutics-inc-information-request-form?prid=7125&wire=1
CCL Shareholders Click Here: https://www.zlk.com/pslra-1/carnival-corporation-loss-submission-form?prid=7125&wire=1

* ADDITIONAL INFORMATION BELOW *

SCWorx Corp. (WORX)

WORX Lawsuit on behalf of: investors who purchased April 13, 2020 - April 17, 2020
Lead Plaintiff Deadline: June 29, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/scworx-corp-loss-submission-form?prid=7125&wire=1

According to the filed complaint, during the class period, SCWorx Corp. made materially false and/or misleading statements and/or failed to disclose that: (1) SCWorx's supplier for COVID-19 tests had previously misrepresented its operations; (2) SCWorx's buyer was a small company that was unlikely to adequately support the purported volume of orders for COVID-19 tests; (3) as a result, the Company's purchase order for COVID-19 tests had been overstated or entirely fabricated; and (4) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

Sorrento Therapeutics, Inc. (SRNE)

SRNE Lawsuit on behalf of: investors who purchased May 15, 2020 - May 20, 2020
Lead Plaintiff Deadline: July 27, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/sorrento-therapeutics-inc-information-request-form?prid=7125&wire=1

According to the filed complaint, during the class period, Sorrento Therapeutics, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) the Company's initial finding of "100% inhibition" in an in vitro virus infection will not necessarily translate to to success or safety in vivo, or in person; (ii) the Company's finding was not a "cure" for COVID-19; and (ii) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Carnival Corporation & Plc (CCL)

CCL Lawsuit on behalf of: investors who purchased January 28, 2020 - May 1, 2020
Lead Plaintiff Deadline: July 27, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/carnival-corporation-loss-submission-form?prid=7125&wire=1

According to the filed complaint, during the class period, Carnival Corporation & Plc made materially false and/or misleading statements and/or failed to disclose that: (1) the Company's medics were reporting increasing events of COVID-19 illness on the Company's ships; (2) Carnival was violating port of call regulations by concealing the amount and severity of COVID-19 infections on board its ships; (3) in responding to the outbreak of COVID-19, Carnival failed to follow the Company's own health and safety protocols developed in the wake of other communicable disease outbreaks; (4) by continuing to operate, Carnival ships were responsible for continuing to spread COVID-19 at various ports throughout the world; and (5) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Levi & Korsinsky is a nationally recognized firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP



View source version on accesswire.com:
https://www.accesswire.com/592652/CLASS-ACTION-UPDATE-for-WORX-SRNE-and-CCL-Levi-Korsinsky-LLP-Reminds-Investors-of-Class-Actions-on-Behalf-of-Shareholders